Why do I care what JL says? Isn't he the one who was staunchly behind Go It Alone?
It's not possible for efficacy to be off the charts and interim analyst to come way before it is expected.
How would that even be possible? They aren't going to look at the data until a specified number of events. And if it is working THAT well, the frequency of events will be lower than expected, so that would only push out the Interim results farther. If Interim results are coming out in June, it is not possible for that to imply 50% efficacy.
You mean INTERIM Reduce-it results, right? Not a chance in H they will ever make it to the final data read out. Which is why, unless the study is stopped at Interim, the stock will, without a doubt, go to $0.
Everyone already knew beforehand the FDA itself is a HUGE risk. The FDA is always one of the biggest of risks. So actions should have been taken BEFORE the Adcom to mitigate the risk of a negative Adcom. Instead stupid management just assumed it would go perfectly as they wanted.
It seems that management of AMRN has no idea about risk management and the hedging of risk. Instead of risking the entire company on the early stoppage of a drug trial, there were a myriad of ways they could have reduced this rick. They could have partnered, sold ex-us rights, diluted at $12 instead of taking on debt, sold the company (with or without a CVR). There were many ways that it didn't have to be this, but management did nothing, and this is the result. Unless this trial is stopped early, this company will go bankrupt and the stock go to $0. There were so many chances for management to take this huge risk off the backs of shareholders, but they failed to do it.
Again, it doesn't matter to management, they already got rich in 2012. So what do they have to lose if it goes to $0? Management owns very few shares.
And you are happy that management has made it this way? That the entire company rests on the early stoppage of a trial?
It's all fine as you long as you recognize that if the trial is not stopped at Interim, AMRN likely goes to $0.
"hopefully PKT doesn't get caught up in any negative effects of investor perceptions about network related stocks."
Good luck with that!
Brear admitted they got it wrong. You are defending that decision? That was a bad bad acquisition any way you slice it! And Brear says they have "corrected" those who provided the analysis. But what is interesting is that ultimately Brear makes that decision and nothing happened to him in the aftermath. This guy pumped Vineyard and pumped it and pumped it, then all the sudden out of nowhere it was an impairment, written down, and a big mistake. Nearly an overnight 180 degree change in tone.
And options and restricted stock aren't skin in the game. If this goes to $0 they lose nothing with regards to those. Real skin in the game is actual ownership of stock, of which almost everyone has very little, due to lack of actual buying and selling in the mid-$20s in 2012.
Your defense of the people who run this company is pretty frightening. Interesting to defend people who have made some pretty bad business decisions resulting in a loss of around 60-70% of your investment value. Just read an article the other day that shows that PKT is now lowing market share to ALLT and SVC. They lost market share during 2014. And you keep defending them?
The only people who have real skin in the game are Mary Losty (owns 171,816 shares) and Thomas Saponos (owns 115,304 shares). The next highest holder is Brear with 40,000 shares, and everyone else owns less than that. Very very little skin in the game here. Is this contributing to many of the bad decisions that have been maid over the last couple of years? They all sold nearly everything back in 2012 in the $20s, so where is the motivation to get this back towards $20?
Absolutely incredible stuff. Huge stock awards for accomplishing absolutely nothing. This is a company that has not released a single positive piece of news in nearly 3 years.
The concern of this management team is NOT Vascepa and making it succeed. It's about bleeding shareholders as much as possible. Any stockholder of Amarin should be absolutely infuriated.
Also, what exactly does John Thero do all day? Seriously, what does he do?
Sherry is the same person who once said to me if I was her child she would abort me.
Yeah, she deserves a lot of respect.
Really really inaccurate statement. But of course that doesn't matter to people on this board. I recommended PKT in the mid to high teens. Yes, it's at $9 now, but it has so much more potential than SPPI going forward. And don't act like SPPI has performed any better since then. SPPI was in the teens when i recommended PKT in the teens.